Vaccines for the prevention of cardiovascular disease

scientific article published on 17 August 2006

Vaccines for the prevention of cardiovascular disease is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VPH.2006.08.004
P698PubMed publication ID17046334

P2093author name stringUna S Ryan
Charles W Rittershaus
P2860cites workCholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosisQ28209813
Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formationQ28275313
Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequencesQ31135771
Immunomodulation of atherosclerosis: implications for vaccine developmentQ34363173
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.Q35590298
Antibody against cholesteryl ester transfer protein (CETP) elicited by a recombinant chimeric enzyme vaccine attenuated atherosclerosis in a rabbit modelQ40413205
Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-Cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivoQ40422178
The safety and immunogenicity of a CETP vaccine in healthy adultsQ40574796
Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention TrialQ43861369
Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptideQ45295828
Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemiaQ46447595
Dibenzodioxocinones--a new class of CETP inhibitorsQ46564413
Medication adherence trends with statinsQ46601441
A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein DeficiencyQ61962950
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportQ63694274
Cholesterol vaccinesQ72409332
Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosisQ74290884
Contraceptive vaccinesQ81479017
Current Drug Options for Raising HDL CholesterolQ81780645
P433issue5
P304page(s)253-257
P577publication date2006-08-17
P1433published inVascular PharmacologyQ7916446
P1476titleVaccines for the prevention of cardiovascular disease
P478volume45

Reverse relations

cites work (P2860)
Q40967621A novel atheroprotective role of MF59-like adjuvant when co-administered with CETP vaccine in rabbit model of atherosclerosis
Q39215603Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis
Q34634698Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management
Q79163371Proceedings of the 8th International Conference on the Vascular Endothelium: Translating Discoveries into Public Health Practice--part I
Q57821678Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis
Q37530710Vaccination for atherosclerosis
Q43251127Vaccination, atherosclerosis and systemic lupus erythematosus

Search more.